$STI
Solidion Technology Inc. Stock $sti

$sti Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000121390024032308 Filed on April 12, 2024

Income Statement

Concept	2024 Q2	2023 Q4	2023
Revenue		$0.00	$0.00
YoY Change			-100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.533M	$1.414M	$3.510M
YoY Change	369.01%	490.22%	288.15%
% of Gross Profit
Research & Development	$400.7K
YoY Change	-41.22%
% of Gross Profit
Depreciation & Amortization	$102.9K
YoY Change
% of Gross Profit
Operating Expenses	$2.933M	$1.414M	$3.510M
YoY Change	448.13%	490.22%	288.15%
Operating Profit	-$2.933M
YoY Change	183.97%
Interest Expense	$24.95M	-$18.05M	-$14.69M
YoY Change	1620.53%	-1787.72%	-907.58%
% of Operating Profit
Other Income/Expense, Net	$24.95M	$0.00	-$14.69M
YoY Change	1619.8%		-899.04%
Pretax Income	$22.02M	-$19.46M	-$18.20M
YoY Change	2304.54%	-2445.74%	-2048.59%
Income Tax	$0.00	$897.7K	$1.580M
% Of Pretax Income	0.0%
Net Earnings	$22.02M	-$20.36M	-$19.78M
YoY Change	3438.69%	-3406.16%	-3429.76%
Net Earnings / Revenue
Basic Earnings Per Share	$0.25
Diluted Earnings Per Share	$0.23	-$3.00	-$1.82
COMMON SHARES
Basic Shares Outstanding	86.90M shares
Diluted Shares Outstanding	96.16M shares

Balance Sheet

Concept	2024 Q2	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$256.5K	$20.00K	$20.00K
YoY Change		-96.33%	-96.33%
Cash & Equivalents	$256.5K	$19.98K
Short-Term Investments
Other Short-Term Assets	$777.1K	$28.33M	$28.33M
YoY Change	288.57%	13039.17%	13039.17%
Inventory	$24.43K	$22.73K
Prepaid Expenses	$267.7K	$85.54K
Receivables	$999.00	$2.164K
Other Receivables	$302.5K	$187.5K
Total Short-Term Assets	$1.629M	$28.35M	$28.35M
YoY Change	925.25%	3624.11%	3624.12%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.194M	$2.319M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments		$42.99M	$42.99M
YoY Change		-66.35%	-66.35%
Other Assets	$778.2K		$0.00
YoY Change			-100.0%
Total Long-Term Assets	$4.910M	$42.99M	$42.99M
YoY Change	-88.24%	-66.36%	-66.36%
TOTAL ASSETS
Total Short-Term Assets	$1.629M	$28.35M	$28.35M
Total Long-Term Assets	$4.910M	$42.99M	$42.99M
Total Assets	$6.540M	$71.35M	$71.35M
YoY Change	-84.39%	-44.51%	-44.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.402M	$2.131M	$2.131M
YoY Change	183.49%	385.32%	385.32%
Accrued Expenses	$890.4K	$890.0K	$890.0K
YoY Change		17700.0%	17700.0%
Deferred Revenue
YoY Change
Short-Term Debt	$3.386M	$2.203M	$2.203M
YoY Change	160.48%	1657.62%	1657.62%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$24.70M	$71.21M	$71.21M
YoY Change	606.43%	7731.44%	7731.37%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$24.70M	$71.21M	$71.21M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$24.70M	$75.54M	$75.54M
YoY Change	215.9%	1343.78%	1343.78%
SHAREHOLDERS EQUITY
Retained Earnings	-$97.70M	-$28.53M
YoY Change	1184.57%	632.55%
Common Stock	$8.709K	$6.980K
YoY Change	72475.0%	58066.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$18.16M	-$28.53M	-$4.191M
YoY Change
Total Liabilities & Shareholders Equity	$6.540M	$71.35M	$71.35M
YoY Change	-84.39%	-44.51%	-44.51%

Cashflow Statement

Concept	2024 Q2	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$22.02M	-$20.36M	-$19.78M
YoY Change	3438.69%	-3406.16%	-3429.76%
Depreciation, Depletion And Amortization	$102.9K
YoY Change
Cash From Operating Activities	-$1.501M	-$516.1K	-$2.661M
YoY Change	42.92%	1698.26%	267.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions		$7.250M
YoY Change
Other Investing Activities	-$66.48K	-$62.90K	$88.58M
YoY Change	-100.07%		-170.32%
Cash From Investing Activities	-$66.48K	-$62.90K	$88.58M
YoY Change	-100.07%		-170.32%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$89.04M
YoY Change			-27.9%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	50.00	597.5K	-$86.44M
YoY Change	-100.0%		-167.94%
NET CHANGE
Cash From Operating Activities	-1.501M	-516.1K	-$2.661M
Cash From Investing Activities	-66.48K	-62.90K	$88.58M
Cash From Financing Activities	50.00	597.5K	-$86.44M
Net Change In Cash	-1.567M	18.50K	-$525.7K
YoY Change	1641.21%	-164.46%	-196.34%
FREE CASH FLOW
Cash From Operating Activities	-$1.501M	-$516.1K	-$2.661M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-41323
CY2023	dei	Entity Registrant Name EntityRegistrantName	SOLIDION TECHNOLOGY, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-1993879
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	13355 Noel Rd
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1100
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Dallas
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75240
CY2023	dei	City Area Code CityAreaCode	(972)
CY2023	dei	Local Phone Number LocalPhoneNumber	918-5120
CY2023	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
CY2023	dei	Trading Symbol TradingSymbol	STI
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	true
CY2023Q2	dei	Entity Public Float EntityPublicFloat	41430352	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	86900398	shares
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	688
CY2023	dei	Auditor Name AuditorName	Marcum llp
CY2023	dei	Auditor Location AuditorLocation	Hartford, CT
CY2023Q4	us-gaap	Cash Cash	19979	usd
CY2022Q4	us-gaap	Cash Cash	545655	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	85538	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	215628	usd
CY2023Q4	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	28245500	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	28351017	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	761283	usd
CY2023Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	42994274	usd
CY2022Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	127782882	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	35870	usd
CY2023Q4	us-gaap	Assets Assets	71345291	usd
CY2022Q4	us-gaap	Assets Assets	128580035	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2131019	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	439086	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	906563	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	339899	usd
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	890385	usd
CY2022Q4	sti	Accrued Offering Costs AccruedOfferingCosts	5000	usd
CY2023Q4	sti	Funds Payable To Redeemed Class A Stockholders FundsPayableToRedeemedClassAStockholders	17834235	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	46728596	usd
CY2023Q4	sti	Advances From Target Current AdvancesFromTargetCurrent	187500	usd
CY2023Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	1297500	usd
CY2022Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	125341	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	71213298	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	909326	usd
CY2023Q4	sti	Deferred Underwriting Commission Non Current DeferredUnderwritingCommissionNonCurrent	4322500	usd
CY2022Q4	sti	Deferred Underwriting Commission Non Current DeferredUnderwritingCommissionNonCurrent	4322500	usd
CY2023Q4	us-gaap	Liabilities Liabilities	75535798	usd
CY2022Q4	us-gaap	Liabilities Liabilities	5231826	usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	24342743	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	127242983	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-28533570	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3895094	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-28533250	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-3894774	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	71345291	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	128580035	usd
CY2023	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	125000	usd
CY2022	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	95000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3384621	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	809193	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	3509621	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	904193	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	18483096	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	3788143	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	1812882	usd
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	8580	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	5683	usd
CY2022	sti	Change In Fair Value Of Overallotment Liability ChangeInFairValueOfOverallotmentLiability	-19432	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-14686373	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1837996	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-18195994	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	933804	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1579608	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	339899	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-19775602	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	593905	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	23570	usd
CY2022	sti	Adjustments To Additional Paid In Capital Proceeds Allocated To Public Warrants AdjustmentsToAdditionalPaidInCapitalProceedsAllocatedToPublicWarrants	3755675	usd
CY2022	sti	Adjustments To Additional Paid In Capital Proceeds From Private Warrants AdjustmentsToAdditionalPaidInCapitalProceedsFromPrivateWarrants	5405000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Mark To Market AdjustmentsToAdditionalPaidInCapitalMarkToMarket	-234654	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	776815	usd
CY2022	us-gaap	Temporary Equity Stock Issued During Period Value New Issues TemporaryEquityStockIssuedDuringPeriodValueNewIssues	12942102	usd
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	-1272983	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	593905	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-3894774	usd
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	-3972489	usd
CY2023	sti	Adjustmentto Accumulated Deficit Excise Tax On Redemption Of Common Stock AdjustmenttoAccumulatedDeficitExciseTaxOnRedemptionOfCommonStock	-890385	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-19775602	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-28533250	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-19775602	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	593905	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	3788143	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	1812882	usd
CY2022	sti	Change In Fair Value Of Overallotment Liability ChangeInFairValueOfOverallotmentLiability	-19432	usd
CY2023	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-18483096	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-130090	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	215628	usd
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-35870	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	35870	usd
CY2023	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-5000	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	566664	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	339899	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1691932	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	424906	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2661093	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-725102	usd
CY2023	sti	Proceeds From Cash Withdrawn For Taxes ProceedsFromCashWithdrawnForTaxes	1523258	usd
CY2023	sti	Proceeds From Cash Withdrawn For Taxes Cash Withdrawn For Redemptions Of Class Common Stock ProceedsFromCashWithdrawnForTaxesCashWithdrawnForRedemptionsOfClassCommonStock	89038494	usd
CY2023	sti	Paymentsforinvestmentofcasin Trust Account PaymentsforinvestmentofcasinTrustAccount	1985000	usd
CY2022	sti	Paymentsforinvestmentofcasin Trust Account PaymentsforinvestmentofcasinTrustAccount	125970000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	88576752	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-125970000	usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1172159	usd
CY2023	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	905000	usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	332500	usd
CY2023	sti	Proceeds Advances From Target ProceedsAdvancesFromTarget	187500	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	89038494	usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	123500000	usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	5405000	usd
CY2022	sti	Payment Of Underwriter Fees PaymentOfUnderwriterFees	1235000	usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	429243	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-86441335	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	127240757	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-525676	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	545655	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	545655	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19979	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	545655	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	1012944	usd
CY2022	sti	Deferred Offering Costs Included In Accrued Offering Costs DeferredOfferingCostsIncludedInAccruedOfferingCosts	25000	usd
CY2022	sti	Deferred Offering Costs Included In Related Party Payable DeferredOfferingCostsIncludedInRelatedPartyPayable	939	usd
CY2022	sti	Deferred Underwriters Compensation Charged To Temporary Equity In Connection With The Public Of DeferredUnderwritersCompensationChargedToTemporaryEquityInConnectionWithThePublicOf	4322500	usd
CY2022	sti	Redeemable Common Stock Measurement Adjustment At Initial Public Offering RedeemableCommonStockMeasurementAdjustmentAtInitialPublicOffering	12942102	usd
CY2022	sti	Fair Value Of Representative Shares FairValueOfRepresentativeShares	776815	usd
CY2022	sti	Fair Value Of Overallotment Option FairValueOfOverallotmentOption	19432	usd
CY2023	sti	Excise Tax On Redemption Of Class A Common Stock ExciseTaxOnRedemptionOfClassACommonStock	890385	usd
CY2023	sti	Common Stock Redeemable Current Period Remeasurement Adjustment CommonStockRedeemableCurrentPeriodRemeasurementAdjustment	3972489	usd
CY2022	sti	Common Stock Redeemable Current Period Remeasurement Adjustment CommonStockRedeemableCurrentPeriodRemeasurementAdjustment	1272983	usd
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	17834235	usd
CY2023	sti	Merger Agreement Description MergerAgreementDescription	(i)5,000,000 Earnout Shares if, over any ten (10) trading days within any thirty (30) trading day period from and after the date that is thirty (30) days following the closing date of the Transactions (the “Closing Date”) until the second anniversary of the Closing Date, the VWAP of the shares of Solidion’s Class A common stock is greater than or equal to $12.50 per share (subject to any adjustment pursuant to the Merger Agreement); (ii)7,500,000 Earnout Shares if, over any ten (10) trading days within any thirty (30) trading day period from and after the date that is one hundred eighty (180) days following the Closing Date until the date that is forty-two (42) months following the Closing Date, the VWAP of the shares of Solidion’s Class A common stock is greater than or equal to $15.00 per share (subject to any adjustment pursuant to the Merger Agreement); and (iii)10,000,000 Earnout Shares if over any ten (10) trading days within any thirty (30) trading day period from and after the date that is one hundred eighty (180) days following the Closing Date until the fourth anniversary of the Closing Date, the VWAP of the shares of Solidion’s Class A common stock is greater than or equal to $25.00 per share (subject to any adjustment pursuant to the Merger Agreement).
CY2023	sti	Percentage Of Aggregate Fair Market Value Of Asset PercentageOfAggregateFairMarketValueOfAsset	0.80	pure
CY2023Q1	us-gaap	Other Ownership Interests Value OtherOwnershipInterestsValue	1235000	usd
CY2023Q1	sti	Price Of Public Share PriceOfPublicShare	0.1
CY2023Q4	sti	Additional Contributed Capital AdditionalContributedCapital	125000	usd
CY2023Q4	sti	Special Meeting Extension SpecialMeetingExtension	750000	usd
CY2023	sti	Aggregate Of Common Stock AggregateOfCommonStock	8430383	shares
CY2023	sti	Cash Withdrawal From Trust Account CashWithdrawalFromTrustAccount	89038494	usd
CY2023	us-gaap	Equity Fair Value Adjustment EquityFairValueAdjustment	900000	usd
CY2023Q4	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	1625876	shares
CY2023Q4	sti	Funds Payable To Redeemed Class A Stockholders FundsPayableToRedeemedClassAStockholders	17834235	usd
CY2023Q4	us-gaap	Net Investment In Lease Current NetInvestmentInLeaseCurrent	5300000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	4100000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.01	pure
CY2023	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	900000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the balance sheet which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p>
CY2023Q4	us-gaap	Interest Receivable InterestReceivable	187000	usd
CY2023	us-gaap	Deferred Compensation Arrangement With Individual Shares Issued DeferredCompensationArrangementWithIndividualSharesIssued	4322500	shares
CY2023	us-gaap	Deferred Compensation Arrangement With Individual Fair Value Of Shares Issued DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued	776815	usd
CY2023Q4	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Amount SharesSubjectToMandatoryRedemptionSettlementTermsAmount	24300000	usd
CY2022Q4	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Amount SharesSubjectToMandatoryRedemptionSettlementTermsAmount	127200000	usd
CY2023	sti	Interest To Pay Distribution Expenses InterestToPayDistributionExpenses	100000	usd
CY2023Q4	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	1625876	shares
CY2023Q4	sti	Funds Payable To Redeemed Class A Stockholders FundsPayableToRedeemedClassAStockholders	17834235	usd
CY2022Q4	sti	Excise Tax Percentage ExciseTaxPercentage	0.01	pure
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	900000	usd
CY2023Q4	us-gaap	Common Stock Dividends Shares CommonStockDividendsShares	1625876	shares
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Concentration of Credit Risk</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account.</p>
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022Q1	sti	Aggregate To Founder Shares AggregateToFounderShares	3162500	shares
CY2022	sti	Number Of Shares Subject To Forfeiture NumberOfSharesSubjectToForfeiture	75000	shares
CY2023Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	1297500	usd
CY2022Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	125341	usd
CY2023	sti	Working Capital Deficit WorkingCapitalDeficit	905000	usd
	sti	Working Capital Deficit WorkingCapitalDeficit	905000	usd
CY2023	us-gaap	Related Party Tax Expense Effect Of Change In Allocation Methodology RelatedPartyTaxExpenseEffectOfChangeInAllocationMethodology	905000	usd
CY2022	us-gaap	Related Party Tax Expense Effect Of Change In Allocation Methodology RelatedPartyTaxExpenseEffectOfChangeInAllocationMethodology	0	usd
CY2023Q2	sti	Advances From Target AdvancesFromTarget	62500	usd
CY2023Q3	sti	Additional Advanced AdditionalAdvanced	62500	usd
CY2023Q3	sti	Additional Advanced AdditionalAdvanced	62500	usd
CY2023Q4	sti	Advances From Target Current AdvancesFromTargetCurrent	187500	usd
CY2023	sti	Related Parties Expenses Paid RelatedPartiesExpensesPaid	332500	usd
CY2022	sti	Related Parties Expenses Paid RelatedPartiesExpensesPaid	2841	usd
CY2023Q4	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	7250000	usd
CY2023	sti	Related Party Transaction Expenses From Transactions With Related Party Per Month RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth	10000	usd
CY2023	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	125000	usd
CY2022	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	95000	usd
CY2023	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	79481	usd
CY2022	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	0	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	1500000	usd
CY2023	sti	Underwriting Cash Discount Per Unit UnderwritingCashDiscountPerUnit	0.1
CY2023	sti	Aggregate Amount AggregateAmount	4322500	usd
CY2023	sti	Cash Payments To Sponsor CashPaymentsToSponsor	7250000	usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	776815	usd
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023	us-gaap	Debt Conversion Converted Instrument Rate DebtConversionConvertedInstrumentRate	0.20	pure
CY2023Q4	us-gaap	Share Price SharePrice	18
CY2023Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	42994274	usd
CY2022Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	127782882	usd
CY2023Q4	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	28245500	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	46728596	usd
CY2023	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	123500	shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	6.29
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	776815	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	369290	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	147881	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	369290	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	147881	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	369290	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	147881	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	1579608	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	339899	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1579608	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	339899	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	221409	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	147481	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Depletion EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepletion	-0.026	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Other EffectiveIncomeTaxRateReconciliationTaxCreditsOther	-0.0846	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.0004	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.0044	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.0122	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.1584	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Exempt Income EffectiveIncomeTaxRateReconciliationTaxExemptIncome	0.0868	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Exempt Income EffectiveIncomeTaxRateReconciliationTaxExemptIncome	0.364	pure
CY2023Q4	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	1625876	shares
CY2023Q4	sti	Funds Payable To Redeemed Class A Stockholders FundsPayableToRedeemedClassAStockholders	17834235	usd
CY2022Q4	us-gaap	Derivative Assets Current DerivativeAssetsCurrent		usd
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent		usd
CY2023Q4	sti	Accrued Offering Costs AccruedOfferingCosts		usd
CY2022Q4	sti	Funds Payable To Redeemed Class A Stockholders FundsPayableToRedeemedClassAStockholders		usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent		usd
CY2022Q4	sti	Advances From Target Current AdvancesFromTargetCurrent		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2023	sti	Change In Fair Value Of Overallotment Liability ChangeInFairValueOfOverallotmentLiability		usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited		usd
CY2023	sti	Change In Fair Value Of Overallotment Liability ChangeInFairValueOfOverallotmentLiability		usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities		usd
CY2022	sti	Proceeds From Cash Withdrawn For Taxes ProceedsFromCashWithdrawnForTaxes		usd
CY2022	sti	Proceeds From Cash Withdrawn For Taxes Cash Withdrawn For Redemptions Of Class Common Stock ProceedsFromCashWithdrawnForTaxesCashWithdrawnForRedemptionsOfClassCommonStock		usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2022	sti	Proceeds Advances From Target ProceedsAdvancesFromTarget		usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
CY2023	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
CY2023	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
CY2023	sti	Payment Of Underwriter Fees PaymentOfUnderwriterFees		usd
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents		usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2023	sti	Deferred Offering Costs Included In Accrued Offering Costs DeferredOfferingCostsIncludedInAccruedOfferingCosts		usd
CY2023	sti	Deferred Offering Costs Included In Related Party Payable DeferredOfferingCostsIncludedInRelatedPartyPayable		usd
CY2023	sti	Deferred Underwriters Compensation Charged To Temporary Equity In Connection With The Public Of DeferredUnderwritersCompensationChargedToTemporaryEquityInConnectionWithThePublicOf		usd
CY2023	sti	Redeemable Common Stock Measurement Adjustment At Initial Public Offering RedeemableCommonStockMeasurementAdjustmentAtInitialPublicOffering		usd
CY2023	sti	Fair Value Of Representative Shares FairValueOfRepresentativeShares		usd
CY2023	sti	Fair Value Of Overallotment Option FairValueOfOverallotmentOption		usd
CY2022	sti	Excise Tax On Redemption Of Class A Common Stock ExciseTaxOnRedemptionOfClassACommonStock		usd
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue		usd
CY2022Q4	sti	Advances From Target Current AdvancesFromTargetCurrent		usd
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2022Q4	us-gaap	Derivative Assets Current DerivativeAssetsCurrent		usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent		usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards		usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards		usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes		pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes		pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Depletion EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepletion		pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Other EffectiveIncomeTaxRateReconciliationTaxCreditsOther		pure
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001881551

Files In Submission

Name	View Source	Status
0001213900-24-032308-index-headers.html	Edgar Link	pending
0001213900-24-032308-index.html	Edgar Link	pending
0001213900-24-032308.txt	Edgar Link	pending
0001213900-24-032308-xbrl.zip	Edgar Link	pending
ea0202064-10k_solidiontech.htm	Edgar Link	pending
ea020206401ex14_solidion.htm	Edgar Link	pending
ea020206401ex31-1_solidion.htm	Edgar Link	pending
ea020206401ex31-2_solidion.htm	Edgar Link	pending
ea020206401ex32-1_solidion.htm	Edgar Link	pending
ea020206401ex32-2_solidion.htm	Edgar Link	pending
ea020206401ex4-4_solidion.htm	Edgar Link	pending
ea020206401ex97_solidion.htm	Edgar Link	pending
ea020206401ex99-1_solidion.htm	Edgar Link	pending
ea020206401ex99-2_solidion.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
image_005.jpg	Edgar Link	pending
image_006.jpg	Edgar Link	pending
image_007.jpg	Edgar Link	pending
image_008.jpg	Edgar Link	pending
image_009.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
ea0202064-10k_solidiontech_htm.xml	Edgar Link	completed
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
sti-20231231.xsd	Edgar Link	pending
sti-20231231_def.xml	Edgar Link	unprocessable
sti-20231231_lab.xml	Edgar Link	unprocessable
sti-20231231_pre.xml	Edgar Link	unprocessable
sti-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$STI
Solidion Technology Inc. Stock $sti

2024 Q2 Form 10-K Financial Statement

#000121390024032308 Filed on April 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$STI Solidion Technology Inc. Stock $sti

2024 Q2 Form 10-K Financial Statement

#000121390024032308 Filed on April 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$STI
Solidion Technology Inc. Stock $sti